The United States Prostate Cancer Biomarkers Market is projected to grow from $1.48 billion in 2024 to $3.54 billion by 2033, ...
Men with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.
Some 17 million Americans are living with genetic mutations tied to an increased risk of getting cancer, Cleveland Clinic ...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
ABP News on MSNOpinion
Male Breast And Prostate Cancer: Why Men’s Cancers Deserve Equal Awareness And Early Detection
Male breast and prostate cancer need equal awareness. Know symptoms, risks, and why early detection and regular screening are ...
TipRanks on MSN
Amgen’s New Prostate Cancer Study: A Potential Game-Changer?
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 1b clinical study ...
India Today on MSN
Why some men don't respond to prostate cancer therapy
The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...
Clarity Pharmaceuticals Ltd. (($AU:CU6)) announced an update on their ongoing clinical study. Clarity Pharmaceuticals Ltd. is conducting a Phase 3 ...
GETTING out of bed in the morning is hard enough, especially now we’re barrelling towards the depths of winter. It’s cold and ...
IS THE PRINCIPAL INVESTIGATOR IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PA / ACCESS Newswire / October 22, 2025 / Medicus ...
WINTERSET, Iowa - Mackenzie Dryden’s happiest childhood memories are of running barefoot through the sunlit corn fields of her hometown. But when she was diagnosed with cancer 2½ years ago at 18 years ...
Dr Drews Adade reveals how bias in medical research leads to missed diagnoses, unequal treatment, and preventable deaths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results